Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 21Lymphoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 7Leukemia 6Hodgkin Disease 6Neoplasm Metastasis 5Lymphoma, B-Cell 4Burkitt Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell, Marginal Zone 3Hemangioma 3Recurrence 2Neoplasms 2Neoplasm, Residual 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Dendritic Cell Sarcoma, Interdigitating 2Breast Neoplasms 2Thymoma 1Stomatitis 1Prostate Cancer Metastatic 1Philadelphia Chromosome 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Paclitaxel 5Vincristine 3Oxaliplatin 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Carboplatin 3Amifostine 3xaliproden 2glucarpidase 2Taxes 2Radiotherapy 2Psychiatric Rehabilitation 2Procarbazine 2Methotrexate 2Magnesium Sulfate 2Leucovorin 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Calcium Gluconate 22,2'-dithiodiethanesulfonic acid 2neurotropin 1glutamic acid diethyl ester 1eribulin 1axicabtagene ciloleucel 1Vitamin E 1Trastuzumab 1Thioctic Acid 1Thalidomide 1Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurotoxicity Syndromes × Prednisolone × Clear all
NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

University College, London

Phase 2 Completed
47 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡